<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>前免疫</title><link/>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;utm_content=101560960&amp;utm_source=Chrome&amp;fc=None&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;ff=20250128151106&amp;utm_campaign=journals<description>前免疫：PubMed的最新结果</description><atom:link href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=101560960%20%5BNLMID%5D&amp;utm_content=101560960&amp;utm_source=Chrome&amp;fc=None&amp;utm_medium=rss&amp;v=2.18.0.post9+e462414&amp;ff=20250128151106&amp;utm_campaign=journals" rel="self"></atom:link><docs> http://www.rssboard.org/rss-specification</docs><generator> PubMed RSS提要（2.18.0.post9+E462414）</generator><language> en</language><lastbuilddate>星期二，2025年1月28日20:11:07 +0000</lastbuilddate><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><ttl> 120</ttl><item><title>酒精摄入通过激活PI3K/AKT/MTOR途径介导的TH1分化加剧了实验性自身免疫前列腺炎</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872540/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>结论：我们的研究是第一个证明酒精摄入量通过激活PI3K/AKT/MTOR途径而加剧EAP的研究。此外，LY294002在抑制PI3K/AKT/MTOR途径中的作用以缓解EAP EAP，这表明它可以作为CP/CPP的有希望的治疗靶标。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1512456。 doi：10.3389/fimmu.2024.1512456。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：流行病学研究表明，酒精消耗与慢性前列腺炎/慢性骨盆疼痛综合征（CP/CPPS）之间存在显着关联。然而，潜在机制仍然不足。这项研究旨在使用动物模型研究酒精对CP/CPP的影响，并阐明基本机制。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们首先建立了广泛使用的CP/CPP动物模型，实验性自身免疫性前列腺炎（EAP）。在诱导EAP期间，用酒精或对照饮食喂养小鼠。使用HE染色，ELISA和行为实验来评估EAP小鼠和EAP茶醇小鼠炎症的严重程度。还包括具有慢性饮酒史的患者，以评估慢性饮酒对CP/CPP的影响。随后，利用蛋白质组学分析，流式细胞仪，免疫荧光，蛋白质印迹和免疫组织化学来研究涉及<i>体内</i>和<i>体外</i>涉及的潜在机制。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：他的染色，ELISA和行为实验表明，酒精会加剧小鼠和患者EAP的严重程度。蛋白质组学和KEGG途径分析表明，异常TH1分化和PI3K/AKT/MTOR途径显着富集。随后的机械研究表明，酒精会显着激活PI3K/AKT/MTOR途径，并增加了<i>体内</i>和<i>体外的</i>Th1细胞分化。相反，PI3K抑制剂LY294002和SHRNA-PI3K质粒抑制了PI3K/AKT/MTOR途径激活，分别减少了Th1细胞分化，并缓解了EAP炎症严重程度。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的研究是第一个证明酒精摄入量通过激活PI3K/AKT/MTOR途径而加剧EAP的研究。此外，LY294002在抑制PI3K/AKT/MTOR途径中的作用以缓解EAP EAP，这表明它可以作为CP/CPP的有希望的治疗靶标。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872540/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872540</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11770681/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11770681</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1512456>10.3389/fimmu.2024.1512456</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872540</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator>苏Xu</dc:creator><dc:creator> Jing Chen</dc:creator><dc:creator> Shaoyu Yue</dc:creator><dc:creator> Yifan Zhang</dc:creator><dc:creator> Shengyu Zhao</dc:creator><dc:creator> Yongtao Hu</dc:creator><dc:creator>张张</dc:creator><dc:creator>Wenrui Guan</dc:creator><dc:creator>李张</dc:creator><dc:creator>Ligang Zhang</dc:creator><dc:creator> Chaozhao Liang</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>酒精摄入通过激活PI3K/AKT/MTOR途径介导的Th1分化加剧了实验性自身免疫性前列腺炎</dc:title><dc:identifier>PMID：39872540</dc:identifier><dc:identifier> PMC：PMC11770681</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1512456</dc:identifier></item><item><title>对霍奇金淋巴瘤发育的专家见解</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872539/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>活化的PI3K三角洲综合征（APDS）是一种主要的免疫缺陷，是由PI3K信号传导途径突变引起的，导致APDS 1和2的功能丧失或功能丧失表型。恶性肿瘤是最严重的并发症之一。与APDS患者有关，最常见的是淋巴瘤，并且是APDS患者最常见的死亡原因。由于疾病的异质性质，APD的管理是复杂而可变的。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1517543。 doi：10.3389/fimmu.2024.1517543。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">活化的PI3K三角洲综合征（APDS）是一种主要的免疫缺陷，是由PI3K信号传导途径突变引起的，导致APDS 1和2的功能丧失或功能丧失表型。恶性肿瘤是最严重的并发症之一。与APDS患者有关，最常见的是淋巴瘤，并且是APDS患者最常见的死亡原因。由于该疾病的异质性质以及从抗菌和免疫抑制剂到造血干细胞移植，因此APD的管理是复杂而可变的。最近，在使用更具靶向剂（例如PI3KΔ特异性抑制剂）中，人们表明了越来越多的关注水平。在这里，我们提供了有关在一名20岁女性患者中观察到的淋巴瘤病例的可疑因果关系的专家观点，该患者被包括在PI3K抑制剂Leniolisib的临床试验中。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872539/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872539</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11770023/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11770023</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1517543>10.3389/fimmu.2024.1517543</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872539</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Francesca Conti</dc:creator><dc:creator>马蒂亚·莫拉蒂（Mattia Moratti）</dc:creator><dc:creator>埃琳娜·萨巴蒂尼（Elena Sabattini）</dc:creator><dc:creator> Pier Luigi Zinzani</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>对霍奇金淋巴瘤发育的专家见解</dc:title><dc:identifier>PMID：39872539</dc:identifier><dc:identifier> PMC：PMC11770023</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1517543</dc:identifier></item><item><title>对子宫内膜异位症中的铁铁病和免疫浸润的新见解：基于生物信息学的分析</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872538/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>结论：我们的研究表明，铁凋亡可能通过重塑免疫微环境共同促进子宫内膜异位症的进展，从而为发病机理和治疗剂提供新的见解。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1507083。 doi：10.3389/fimmu.2024.1507083。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：最近发现的铁依赖性细胞死亡的铁铁作用与各种疾病有关，但其在子宫内膜异位症中的作用仍未完全了解。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项研究中，我们整合了来自GEO数据库的子宫内膜异位症和来自FERRDB数据库中与铁凋亡相关的基因（FRG）的微阵列数据，以进一步研究子宫内膜异位症中的铁凋亡调节及其对免疫微环境的影响。 WGCNA鉴定出与GO＆KEGG注释的与铁毒相关的模块。跨国公司算法指标的轮毂FRG。 Cytoscape构建了CERNA网络，ROC曲线评估了轮毂FRG的诊断功效。共识群集分析确定了铁毒性亚簇，Cibersort评估了这些子截面的免疫浸润。最后，RT-QPCR验证了临床组织中的HUB FRG表达。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们确定了子宫内膜异位症的两个铁凋亡模块，通过富集分析，它们与自噬，mTOR，氧化应激和FOXO途径密切相关。此外，我们确定了10个枢纽FRG，ROC曲线显示出更好的诊断预测能力。 RT-QPCR证实了10个枢纽FRG的组织表达与数据库结果一致。随后，我们开发了一个基于4个FRG（BECN1，OSBPL9，TGFBR1，GSK3B）的CERNA网络。接下来，我们确定了子宫内膜异位症的两个铁毒性亚簇，并发现它们与子宫内膜异位症阶段密切相关。重要的是，免疫富集分析表明，在两个铁铁毒性亚簇中，免疫细胞和免疫检查点基因的表达水平显着差异。具体而言，具有子宫内膜异位症III期IV期的铁吞作用簇更倾向于免疫抑制微环境。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的研究表明，铁凋亡可能通过重塑免疫微环境共同促进子宫内膜异位症的进展，从而为发病机理和治疗剂提供新的见解。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872538/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872538</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769811/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769811</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1507083>10.3389/fimmu.2024.1507083</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872538</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Lusha Liu</dc:creator><dc:creator> Feifei Han</dc:creator><dc:creator> Naiyi du</dc:creator><dc:creator> Yakun Liu</dc:creator><dc:creator> Aihong Duan</dc:creator><dc:creator> Shan Kang</dc:creator><dc:creator>本·李</dc:creator><dc:date>2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>对子宫内膜异位症中的铁铁病和免疫浸润的新见解：基于生物信息学的分析</dc:title><dc:identifier>PMID：39872538</dc:identifier><dc:identifier> PMC：PMC11769811</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1507083</dc:identifier></item><item><title>胎儿绒毛组织的免疫景观</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872537/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>简介：胎儿绒毛膜绒毛内的免疫室由胎儿霍夫鲍尔细胞（HBC）组成，胎盘相关的母体单核细胞和巨噬细胞（PAMM）组成。最近的研究表征了头三个月（T1）胎盘的转录特征。然而，学期（T3）的绒毛膜绒毛免疫细胞的表型和功能多样性仍然鲜为人知。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1506305。 doi：10.3389/fimmu.2024.1506305。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：胎儿绒毛膜绒毛内的免疫室由胎儿霍夫鲍尔细胞（HBC）组成，胎盘相关的母体单核细胞和巨噬细胞（PAMM）组成。最近的研究表征了头三个月（T1）胎盘的转录特征。然而，学期（T3）的绒毛膜绒毛免疫细胞的表型和功能多样性仍然鲜为人知。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：为了解决这一知识差距，使用流式细胞仪，单细胞RNA测序（SCRNA-SEQ，CITE-SEQ）和染色质访问性，深入表型，从成熟，简单怀孕中获得的人绒毛膜绒毛组织的免疫细胞深层表型。分析（snatac-seq）。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的结果表明，相对于头三个月，胎儿巨噬细胞的频率（HBC，增殖HBC）显着降低，而T3中会增加T3中的母体单核细胞/巨噬细胞/巨噬细胞（PAMM1B，PAMM1A，PAMM1A，PAMM2，MAC_1）的频率。 PAMM1B和HBC在妊娠晚期中强调其在组织稳态中的调节作用时表现出最大的吞噬能力。相对于T1，居民绒毛免疫亚群的转录曲线表现出增强的激活状态，可能支持劳动和分娩。此外，我们在学期提供了对绒毛髓样细胞的染色质可及性概况的最初见解之一。接下来，我们通过孕前BMI对发现进行了分层，因为孕产妇的孕妇肥胖与几种不良妊娠结局有关。毛刺肥胖增加了炎症基因的表达，特别是在HBC和PAMM1A亚群中，但抑制了抗菌基因的表达，支持绒毛膜绒毛髓样细胞的耐受性表型。我们报告说，HBC丰度下降，伴随着浸润性巨噬细胞的增加，这与绒毛膜绒毛炎性病理增强的报道与预涂层肥胖有关。最后，鉴于HBC和小胶质细胞的共享胎儿蛋黄-SAC起源，我们利用了脐带血液衍生的小胶质细胞的<i>体外</i>模型来研究预盖肥胖对胎儿神经发育的影响。我们的发现表明，激活标志物的表达增加，尽管伴有毛胶质细胞的吞噬能力抑制了吞噬能力。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">讨论：总体而言，我们的研究突出了具有胎龄和牙周肥胖症的胎儿绒毛膜绒毛的免疫适应性，以及对小胶质细胞功能障碍的洞察力可能会导致较差的神经发育效果，而神经发育效果可能会导致妇女的妇女的妇女的妇女的妇女。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872537/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872537</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769816/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769816</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1506305>10.3389/fimmu.2024.1506305</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872537</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Brianna M Doratt</dc:creator><dc:creator> Heather E真实</dc:creator><dc:creator>Suhas Sureshchandra</dc:creator><dc:creator> Qi Qiao</dc:creator><dc:creator>莫妮卡·林肯（Monica Rincon）</dc:creator><dc:creator>妮可·马歇尔（Nicole E Marshall）</dc:creator><dc:creator>伊利姆·梅索迪（Ilhem Messaoudi）</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>胎儿绒毛组织的免疫景观</dc:title><dc:identifier>PMID：39872537</dc:identifier><dc:identifier> PMC：PMC11769816</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1506305</dc:identifier></item><item><title>整个转录组的分析揭示了猪肺泡巨噬细胞中对猪繁殖和呼吸综合征病毒感染和Tylvalosin arttrate治疗的免疫反应</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872536/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>结论：我们的数据为PRRSV和Tylvalosin tartrates提供了关键非编码RNA的目录，并可能丰富了未来PRRSV预防和控制的遗传基础。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1506371。 doi：10.3389/fimmu.2024.1506371。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：猪生殖和呼吸综合症病毒（PRRSV）是一种主要的病原体，在猪工业中造成了严重的经济损失。筛选猪肺泡巨噬细胞（PAM）中与宿主免疫相关的遗传因子对于提高猪的抗病毒能力至关重要。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这项研究中，设置了一个<i>体内</i>模型，以评估Tylvalosin tartrates的抗PRRSV效应。然后，进行了链特异性的RNA测序（SSRNA-SEQ）和miRNA-Sequencing（miRNA-Seq），以在阴性对照，PRRSV感染的PAM和Tylvalosin tartrates-prates-Partates-Partates-Partates-prestrates-PART组中介绍PAMS的整个转录组。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：SSRNA-SEQ在PAM中鉴定出11740长的非编码RNA。基于我们的注意机制改进的图形卷积网络，预计分别位于核和细胞质中的41.07％和28.59％的LNCRNA。 miRNA-seq揭示了Tylvalosin tarrates增强的miRNA可能在调节血管生成和与先天免疫相关的功能中起着作用，并且挽救了三种抗炎症miRNA的表达（ <i>SSC-MIR-30A-5P</i> ， <i>SSC-MIR-218---5P，SSC-MIR-30A-</i> 5P由于PRRSV感染而被下调的<i>5p</i>和<i>SSC-MIR-218</i> ）。 Tylvalosin Tarrates增强的细胞质LNCRNA可能与miRNA形成Cerna网络，以调节PAM趋化性。虽然由Tylvalosin tartrates救出的细胞质LNCRNA可能通过与吞噬相关的CERNA网络保护PAM。另一方面，TylValosin artrates验证的核LNCRNA可能会负调节T细胞凋亡，并与关键的抗炎因子IL37结合，以通过<i>顺式</i>和<i>反式</i>调节来保护肺。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：我们的数据为PRRSV和Tylvalosin tartrates提供了关键非编码RNA的目录，并可能丰富了未来PRRSV预防和控制的遗传基础。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872536/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872536</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769836/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769836</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1506371>10.3389/fimmu.2024.1506371</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872536</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Kun du</dc:creator><dc:creator> Yu Xia</dc:creator><dc:creator>吴吴</dc:creator><dc:creator>Miao Yin</dc:creator><dc:creator> Hong Zhao</dc:creator><dc:creator> xi-wen chen</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>整个转录组的分析揭示了猪肺泡巨噬细胞中对猪繁殖和呼吸综合征病毒感染和Tylvalosin arttrate治疗的免疫反应</dc:title><dc:identifier>PMID：39872536</dc:identifier><dc:identifier> PMC：PMC11769836</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1506371</dc:identifier></item><item><title>病例报告：efgartigimod是眼部肌无力的新型治疗选择：2例病例的报告</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872535/？<description>结论：本文所述的2例为Efgartigimod治疗OMG的有效性提供了对不反应或不耐受常规药物的患者的有效性的初步证据。需要进行大规模研究来确认这些发现。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1497398。 doi：10.3389/fimmu.2024.1497398。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：efgartigimod已批准用于治疗乙酰胆碱受体抗体阳性重症肌无力的肌无力（ACHR-AB+GMG），但尚不清楚其在眼部肌无力的肌无力（OMG）患者中的疗效。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">案例表现：我们描述了2例ACHR-AB+ OMG患者对皮质类固醇和他克莫司的反应不佳的病例。在启动Efgartigimod的2周内，两名患者在第3至4周的症状表达迅速，症状表达最小，直到第12周才保持。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：本文所述的2例为Efgartigimod治疗OMG的有效性提供了对不反应或不耐受常规药物的患者的有效性的初步证据。需要进行大规模研究来确认这些发现。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872535/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872535</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769809/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769809</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1497398>10.3389/fimmu.2024.1497398</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872535</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator>田尼·马</dc:creator><dc:creator>Ying Zhu</dc:creator><dc:creator> Ruixia Zhu</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>病例报告：efgartigimod是眼部肌无力的新型治疗选择：2例病例的报告</dc:title><dc:identifier>PMID：39872535</dc:identifier><dc:identifier> PMC：PMC11769809</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1497398</dc:identifier></item><item><title>单细胞RNA-seq揭示了人类纤维化皮肤疾病中的免疫细胞异质性和增加的Th17细胞</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872534/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>结论：总而言之，我们在这项研究中建立了一个纤维化皮肤疾病的单细胞地图集。此外，我们探索了Th17细胞成纤维细胞相互作用在皮肤纤维化中的功能。这些发现将有助于了解深度纤维化皮肤病的发病机理，并确定纤维化皮肤病治疗的潜在靶标。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1522076。 doi：10.3389/fimmu.2024.1522076。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：纤维化皮肤疾病代表了全球主要的医疗保健负担，其特征是成纤维细胞超增殖和细胞外基质成分的过度积累。假设免疫细胞在纤维化皮肤病的发展中发挥关键作用。单细胞RNA测序已用于探索纤维化皮肤疾病中存在的免疫细胞的组成和功能。但是，这些研究检测到纤维化皮肤疾病中所有细胞的基因表达，并且没有富集免疫细胞。因此，纤维化皮肤疾病中的精确免疫细胞图谱仍然未知。在这项研究中，我们计划研究Keloid免疫细胞的复杂细胞景观，乳腺癌是纤维化皮肤疾病的范式。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：CD45 <sup>+</sup>免疫细胞通过荧光激活的细胞分选富集。单细胞RNA测序用于分析酮和正常疤痕组织中免疫细胞的细胞景观。 Ki-67染色，刮擦实验，实时PCR和蛋白质印迹用于探索Th17细胞上清液对乳子纤维细胞的影响。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的发现揭示了纤维化皮肤疾病中免疫细胞的复杂细胞景观。我们发现，与正常疤痕相比，Keloids中Th17细胞的百分比显着增加。巨噬细胞和树突状细胞（DC）的所有子截面显示酮样样品与正常疤痕样品之间的比例相似。然而，Keloid M1巨噬细胞，M2巨噬细胞和CDC2中的基因上调与MHC II类蛋白质复合物组装和抗原组装有关，表明巨噬细胞和CDC2在乳突中活跃。功能研究表明，Th17细胞的上清液可以促进乳头成纤维细胞通过白介素17a的增殖，胶原蛋白表达和迁移。重要的是，在其他纤维化皮肤疾病（例如肥厚疤痕和硬皮病）中也发现了增加的Th17细胞，这表明这代表了皮肤纤维化的广泛机制。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：总而言之，我们在这项研究中建立了一个纤维化皮肤疾病的单细胞地图集。此外，我们探索了Th17细胞成纤维细胞相互作用在皮肤纤维化中的功能。这些发现将有助于了解深度纤维化皮肤病的发病机理，并确定纤维化皮肤病治疗的潜在靶标。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872534/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872534</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769821/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769821</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1522076>10.3389/fimmu.2024.1522076</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872534</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator>昌尚</dc:creator><dc:creator>Xue-Yan Xu</dc:creator><dc:creator> Yan Zhang</dc:creator><dc:creator>长牛刘</dc:creator><dc:creator>Xuan Wang</dc:creator><dc:creator> Jun-Yi Chen</dc:creator><dc:creator> Liu-Yi Yao</dc:creator><dc:creator>丁朱</dc:creator><dc:creator>本杨</dc:creator><dc:date>2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>单细胞RNA-seq揭示了人类纤维化皮肤疾病中的免疫细胞异质性和增加的Th17细胞</dc:title><dc:identifier>PMID：39872534</dc:identifier><dc:identifier> PMC：PMC11769821</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1522076</dc:identifier></item><item><title> NK细胞相关LNCRNA对胰腺导管腺癌的免疫微环境和分子亚型的影响</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872533/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>结论：这项研究发现了NK细胞在PDAC中的活性，提出了与NK细胞相关的LNCRNA模型，并描绘了新的分子亚型，从而为个性化治疗提供了靶标。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1514259。 doi：10.3389/fimmu.2024.1514259。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：胰腺导管腺癌（PDAC）的患者面临高度不利的结果，对标准治疗的反应较差。免疫疗法，尤其是基于天然杀手（NK）细胞的治疗，为PDAC治疗提供了有希望的途径。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：这项研究努力旨在制定一种针对PDAC设计的预测工具，该工具基于NK细胞相关的长期非编码RNA（LNCRNA），揭示了PDAC的新分子亚型，以促进个性化和精确处理。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：利用肿瘤免疫单细胞轮毂2平台，我们发现了与PDAC中NK细胞相关的基因。我们使用TCGA-PAAD数据集来确定这些NK细胞相关基因的表达谱，并筛选与NK细胞相关的LNCRNA。随后，我们利用COX回归分析来危害比率和LASSO回归分析，以识别用于开发预后评估模型的三种NK细胞相关的LNCRNA。使用ROC曲线评估了该模型的预测精度，并使用测试集和完整的数据集进行了验证。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：成功构建了包括三个LNCRNA的预后模型，证明了训练集，验证数据集和整个数据集的良好预测效率。 NK细胞在PDAC肿瘤微环境中与恶性细胞，CD8 T细胞和成纤维细胞表现出牢固的相互作用，并参与PDAC中的各种信号分子的运输以及后反应后的传递。根据NK细胞相关LNCRNA的表达模式，我们将PDAC患者标记为四个分子亚型，在免疫细胞浸润，药物敏感性和其他方面表现出显着差异。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：这项研究发现了NK细胞在PDAC中的活性，提出了与NK细胞相关的LNCRNA模型，并描绘了新的分子亚型，从而为个性化治疗提供了靶标。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872533/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872533</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11770056/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11770056</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1514259>10.3389/fimmu.2024.1514259</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872533</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Jinze li</dc:creator><dc:creator> chuqi xia</dc:creator><dc:creator> Yuxuan li</dc:creator><dc:creator> Hanhan Liu</dc:creator><dc:creator>郑彩</dc:creator><dc:creator>liang</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>NK细胞相关LNCRNA对胰腺导管腺癌的免疫微环境和分子亚型的影响</dc:title><dc:identifier>PMID：39872533</dc:identifier><dc:identifier> PMC：PMC11770056</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1514259</dc:identifier></item><item><title>支气管肺泡灌洗液&lt;em>; CD44 &lt;/em>;作为弥漫性实质肺部疾病中肺纤维化的标记</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872532/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>简介：弥漫性实质肺疾病（DPLD）涵盖了肺部疾病的异质类型。在许多病理表型中，肺纤维化是最具破坏性的，它代表了特发性肺纤维化（IPF）的特征迹象。尽管肺纤维化带来的预后较差，但对于这种致命状况的初步发展尚无特定的诊断生物标志物。肺纤维化的主要标志是肺成纤维细胞的激活不受控制。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1479458。 doi：10.3389/fimmu.2024.1479458。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">简介：弥漫性实质肺疾病（DPLD）涵盖了肺部疾病的异质类型。在许多病理表型中，肺纤维化是最具破坏性的，它代表了特发性肺纤维化（IPF）的特征迹象。尽管肺纤维化带来的预后较差，但对于这种致命状况的初步发展尚无特定的诊断生物标志物。肺纤维化的主要标志是肺成纤维细胞不受控制地激活与细胞外基质沉积相关的肌纤维细胞以及肺结构和功能的丧失。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：在这里，我们使用了这种特殊的特征，以鉴定支气管肺泡灌洗液（BALF）中肺纤维化的特定生物标志物。主要的MRC-5人成纤维细胞被从临床诊断的肺纤维化患者中收集的BALF激活。然后严格洗涤活化的成纤维细胞，然后进一步孵育以允许分泌。之后，通过质谱法分析了秘密组。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：通过这种方式，发现了<i>CD44</i>蛋白；因此，ELISA对所有<i>DPLD</i>患者的BALF进行了积极测试。最后，生化和生物物理特征揭示了<i>CD44</i>的外骨骼起源。接收器操作特性曲线分析证实了BALF中的<i>CD44</i>是IPF的特定可靠生物标志物以及其他类型的DPLD，并伴有肺纤维化。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872532/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872532</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769834/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769834</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1479458>10.3389/fimmu.2024.1479458</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872532</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Magda Suchankova</dc:creator><dc:creator> Eszter Zsemlye</dc:creator><dc:creator> Jan Urban</dc:creator><dc:creator>彼得·巴拉斯</dc:creator><dc:creator>LenkaKohútová</dc:creator><dc:creator>芭芭拉·西瓦科瓦（BarbaraSiváková）</dc:creator><dc:creator> Martina Ganovska</dc:creator><dc:creator>埃琳娜·蒂本斯卡（Elena Tibenska）</dc:creator><dc:creator> Kinga Szaboova</dc:creator><dc:creator>伊娃·特德洛娃（Eva Tedlova）</dc:creator><dc:creator> Dominik Juskanic</dc:creator><dc:creator>克里斯蒂娜·克拉科娃（Kristina Kluckova）</dc:creator><dc:creator> Michaela Kardohelyova</dc:creator><dc:creator>提亚娜·莫斯凯特（Tetiana Moskalets）</dc:creator><dc:creator> Anna Ohradanova-Repic</dc:creator><dc:creator> Patrik Babulic</dc:creator><dc:creator>玛丽亚·布科娃（Maria Bucova）</dc:creator><dc:creator>弗拉基米尔·莱克萨（Vladimir Leksa）</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>支气管肺泡灌洗液&lt;em>; CD44 &lt;/em>;作为弥漫性实质肺部疾病中肺纤维化的标记</dc:title><dc:identifier>PMID：39872532</dc:identifier><dc:identifier> PMC：PMC11769834</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1479458</dc:identifier></item><item><title>与同时发生AQP4-IGG阳性神经瘤谱系障碍和肌无力的患者的患者治疗：病例报告和文献综述</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872531/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description>结论：尽管MG通常在NMOSD和胸腺切除术之前经常进行，但它不是NMOSD发育的先决条件，但可能代表了潜在的危险因素。与NMOSD更具侵略性的性质相比，MG通常遵循良性课程。两种NMOSD和MG结合使用的生物学剂，例如静脉内的生物学剂，请先进一步关注。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1528989。 doi：10.3389/fimmu.2024.1528989。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">目的：这项研究旨在描述临床特征的临床特征，即神经瘤谱谱系疾病（NMOSD）和Gravis（MG）的临床特征，并确定有效的治疗策略。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：NMOSD和MG是很少见的自身免疫性疾病，不经常共存。尽管以前有报道，但仍缺乏就NMOSD同时发生的共识。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：我们介绍了一名55岁的女性抗Aquaporin-4（AQP4）抗体阳性NMOSD和抗乙酰胆碱受体（ACHR）抗体阳性MG的情况没有明显的不利影响。我们还进行了文献综述，以评估这种合并症的临床特征。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结果：我们的审查确定了85例并发NMOSD和MG患者。在70例有据可查的病例中，MG早于60例（85.8％）的NMOSD，有42例接受胸腺切除术的患者。首先被诊断为NMOSD，六名（8.6％）患者，然后在2（33.3％）毫克患者中进行胸腺切除术。对于NMOSD治疗，尽管大多数患者接受了类固醇激素和免疫抑制剂，但相当多的患者持续严重残疾。此外，在44例疾病复发记录的患者中，有31名患者（70.5％）经常出现视神经炎和脊髓炎的复发，范围为1至15次攻击，平均5例。 MG的表现主要包括疲劳性，复视和孔透析，大多数患者的症状得到了很好的控制。我们的患者接受了静脉内三单抗治疗1年，迄今未记录复发。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">结论：尽管MG通常在NMOSD和胸腺切除术之前经常进行，但它不是NMOSD发育的先决条件，但可能代表了潜在的危险因素。与NMOSD更具侵略性的性质相比，MG通常遵循良性课程。两种NMOSD和MG结合使用的生物学剂，例如静脉内的生物学剂，请先进一步关注。</p><p style="color: lightgray"> PMID： <a href="https://pubmed.ncbi.nlm.nih.gov/39872531/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872531</a> | PMC： <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769772/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769772</a> | doi： <a href=https://doi.org/10.3389/fimmu.2024.1528989>10.3389/fimmu.2024.1528989</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> PubMed：39872531</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator>小qian歌</dc:creator><dc:creator>Jingjiao Chen</dc:creator><dc:creator> Chenyang Jin</dc:creator><dc:creator> Yilong Peng</dc:creator><dc:creator> Yuewen Sun</dc:creator><dc:creator> Xueping Zheng</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>与同时发生AQP4-IGG阳性神经瘤谱系障碍和肌无力的患者的患者治疗：病例报告和文献综述</dc:title><dc:identifier>PMID：39872531</dc:identifier><dc:identifier> PMC：PMC11769772</dc:identifier><dc:identifier> doi：10.3389/fimmu.2024.1528989</dc:identifier></item><item><title>鉴定和验证BATF作为预后生物标志物和急性髓样白血病中免疫细胞浸润的调节剂</title><link/>https://pubmed.ncbi.nlm.nih.gov/39872530/？<description>结论：生物信息学分析和实验验证表明，BATF表达可以改变AML中CD8^（+）T细胞和NK细胞的比例并影响药物敏感性，从而使其成为AML的潜在治疗靶标。 </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025年1月13日； 15：1429855。 doi：10.3389/fimmu.2024.1429855。环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">背景：基本亮氨酸拉链类ATF样转录因子（BATF）是与AP-1/ATF超家族相关的核基本亮氨酸拉链蛋白。先前的研究证实，BATF表达在肿瘤微环境中起着重要作用。然而，急性髓样白血病（AML）患者的BATF表达与预后之间的关联及其免疫学作用尚不清楚。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">方法：基因组和临床AML数据来自TCGA（TCGA-LAML）和GEO（GSE37642）数据库，以进行后续分析。使用GEPIA评估AML患者中BATF的表达水平，并通过QRT-PCR和Western印迹验证了结果。同时，使用单变量和多变量分析，接收器操作特征（ROC）曲线（AUC）分析以及Kaplan-Meier（KM）生存分析评估了BATF的预后值。使用EDU，菌落形成和CCK-8测定法来评估细胞的增殖。此外，我们通过数据库分析和<i>体内</i>实验检测到BATF表达与药物敏感性的关联。为了进一步研究BATF在AML中的作用机理，进行了RNA测序（RNA-SEQ）分析，然后使用基因和基因组的京都百科全书（KEGG）途径分析进行途径富集分析。同时，我们通过C1498 AML小鼠模型中的流式细胞仪检测到BATF表达与免疫细胞比例之间的联系。最后，我们使用单细胞测序研究了AML细胞种群中BATF表达与细胞 - 细胞通信之间的关联。 </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: In this study, we thoroughly investigated the role of BATF in AML. First, we observed a significant elevation in the expression of BATF in patients and cells in AML. Further analysis revealed an association between high BATF expression and poor prognosis in AML. Additionally, BATF expression was found to promote the proliferative capacity of AML cells. Moreover, the results showed that the expression level of BATF dramatically affected the effect of chemotherapy in AML patients. We also discovered that BATF expression could activate multiple immune-related pathways, altering the proportions of CD8 <sup>+</sup> T cells and NK cells, suggesting that BATF may be a regulator of immune cell infiltration. Finally, there were differences in receptor ligand pairs between AML cells with high and low expression of BATF and immune cells. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: Bioinformatics analysis and experimental verification revealed that BATF expression could alter the proportions of CD8 <sup>+</sup> T cells and NK cells in AML and affect drug sensitivity, making it a potential treatment target for AML.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39872530/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872530</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769954/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769954</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2024.1429855>10.3389/fimmu.2024.1429855</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39872530</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Zhe Zhao</dc:creator><dc:creator> Dongmei Wang</dc:creator><dc:creator> Xue Sheng</dc:creator><dc:creator> Shuying Li</dc:creator><dc:creator> Tingting Liu</dc:creator><dc:creator> Mengyuan Chang</dc:creator><dc:creator> Lei Feng</dc:creator><dc:creator> Di Zhang</dc:creator><dc:creator> Chunyan Ji</dc:creator><dc:creator> Fei Lu</dc:creator><dc:creator> Jingjing Ye</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia</dc:title><dc:identifier> pmid:39872530</dc:identifier><dc:identifier> pmc:PMC11769954</dc:identifier><dc:identifier> doi:10.3389/fimmu.2024.1429855</dc:identifier></item><item><title> Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages</title><link/> https://pubmed.ncbi.nlm.nih.gov/39872529/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description> INTRODUCTION: Recent epidemiological data suggests a rising incidence of breast angiosarcoma (AS-B) in the Western population, with over two-thirds related to irradiation or chronic lymphedema. However, unlike head and neck angiosarcoma (AS-HN), AS-B disease characteristics in Asia remain unclear. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 13;15:1515935. doi: 10.3389/fimmu.2024.1515935.环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> INTRODUCTION: Recent epidemiological data suggests a rising incidence of breast angiosarcoma (AS-B) in the Western population, with over two-thirds related to irradiation or chronic lymphedema. However, unlike head and neck angiosarcoma (AS-HN), AS-B disease characteristics in Asia remain unclear. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: We examined clinical patterns of angiosarcoma patients (n = 176) seen in an Asiantertiary cancer center from 1999 to 2021, and specifically investigated the molecular and immune features of AS-B in comparison to AS-HN. Data from whole genome sequencing (WGS), NanoString gene expression profiling and 10x Genomics Visium spatial transcriptomics were analyzed. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Majority of cases were AS-HN (n = 104; 59.1%), while AS-B (n = 16, all females) accounted for 9.1% of the cases. The median age at diagnosis was 43 years (range, 26 to 74). Based on WGS, 4 of the 7 AS-B had non-synonymous somatic variants in 47 genes (range, 2 to 28 per case). These genes were functionally annotated and were enriched in cancer-related pathways such as regulation of cell differentiation, VEGFR and receptor tyrosine kinases signaling pathways. By NanoString gene expression profiling, ASB, compared to AS-HN, were enriched for angiogenesis, notch signaling and metastasis-associated matrix remodeling pathways. Additionally, AS-B were enriched for macrophages and CD8+ T cells expression signatures. Similarly, Visium spatial transcriptomics showed that AS-B were enriched for macrophages and T-cells. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> DISCUSSION: In conclusion, in our AS-B cases, we observed a convergence of both mutational and expression signatures on angiogenic-related pathways. Thus, anti-angiogenic therapy could be an option to treat AS-B.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39872529/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872529</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11770038/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11770038</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2024.1515935>10.3389/fimmu.2024.1515935</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39872529</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Tun Kiat Ko</dc:creator><dc:creator> Zexi Guo</dc:creator><dc:creator> Bavani Kannan</dc:creator><dc:creator> Boon Yee Lim</dc:creator><dc:creator> Jing Yi Lee</dc:creator><dc:creator> Zhimei Li</dc:creator><dc:creator> Elizabeth Chun Yong Lee</dc:creator><dc:creator> Bin Tean Teh</dc:creator><dc:creator> Jason Yongsheng Chan</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Multiomics characterization of breast angiosarcoma from an Asian cohort reveals enrichment for angiogenesis signaling pathway and tumor-infiltrating macrophages</dc:title><dc:identifier> pmid:39872529</dc:identifier><dc:identifier> pmc:PMC11770038</dc:identifier><dc:identifier> doi:10.3389/fimmu.2024.1515935</dc:identifier></item><item><title> Case report: A rollercoaster journey of pemphigus vegetans</title><link/> https://pubmed.ncbi.nlm.nih.gov/39872528/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description> Pemphigus vegetans (P Veg), the rarest subtype of pemphigus, is characterized by vegetative plaques, primarily affecting intertriginous areas. The most common autoantibodies target desmoglein 3 (Dsg3). A 60-year-old female patient presented with well-demarcated red vegetative plaques on her feet, vulva, and thigh, accompanied by surrounding pustules. Histopathological examination revealed epidermal hyperplasia with significant infiltration of neutrophils and eosinophils in the dermis.... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 13;15:1481192. doi: 10.3389/fimmu.2024.1481192.环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> Pemphigus vegetans (P Veg), the rarest subtype of pemphigus, is characterized by vegetative plaques, primarily affecting intertriginous areas. The most common autoantibodies target desmoglein 3 (Dsg3). A 60-year-old female patient presented with well-demarcated red vegetative plaques on her feet, vulva, and thigh, accompanied by surrounding pustules. Histopathological examination revealed epidermal hyperplasia with significant infiltration of neutrophils and eosinophils in the dermis. Enzyme-linked immunosorbent assay showed elevated anti-Dsg3 antibodies (203.2 U/ml), and immunohistochemical staining confirmed positive expression of anti-Dsg3 IgG antibodies in keratinocytes. The patient was diagnosed with P Veg and achieved remission after treatment with either 900 mg of intravenous spesolimab or oral methylprednisolone.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39872528/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872528</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769805/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769805</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2024.1481192>10.3389/fimmu.2024.1481192</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39872528</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Xiaoyuan Hou</dc:creator><dc:creator> Jia Chen</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Case report: A rollercoaster journey of pemphigus vegetans</dc:title><dc:identifier> pmid:39872528</dc:identifier><dc:identifier> pmc:PMC11769805</dc:identifier><dc:identifier> doi:10.3389/fimmu.2024.1481192</dc:identifier></item><item><title> Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically &#39;cold&#39; tumor models</title><link/> https://pubmed.ncbi.nlm.nih.gov/39872527/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description> INTRODUCTION: Hyperthermia is an established adjunct in multimodal cancer treatments, with mechanisms including cell death, immune modulation, and vascular changes. Traditional hyperthermia applications are resource-intensive and often associated with patient morbidity, limiting their clinical accessibility. Gold nanorods (GNRs) offer a precise, minimally invasive alternative by leveraging near-infrared (NIR) light to deliver targeted hyperthermia therapy (THT). THT induces controlled tumor... </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 13;15:1512543. doi: 10.3389/fimmu.2024.1512543.环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> INTRODUCTION: Hyperthermia is an established adjunct in multimodal cancer treatments, with mechanisms including cell death, immune modulation, and vascular changes. Traditional hyperthermia applications are resource-intensive and often associated with patient morbidity, limiting their clinical accessibility. Gold nanorods (GNRs) offer a precise, minimally invasive alternative by leveraging near-infrared (NIR) light to deliver targeted hyperthermia therapy (THT). THT induces controlled tumor heating, promoting immunogenic cell death (ICD) and modulating the tumor microenvironment (TME) to enhance immune engagement. This study explores the synergistic potential of GNR-mediated THT with immunotherapies in immunogenically &#39;cold&#39; tumors to achieve durable anti-tumor immunity. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: GNRs from Sona Nanotech Inc.™ were intratumorally injected and activated using NIR light to induce mild hyperthermia (42-48°C) for 5 minutes. Tumor responses were analyzed for cell death pathways and immune modulation. The immunogenic effects of THT were assessed alone and in combination with intratumoral interleukin-2 (it IL-2) or systemic PD-1 immune checkpoint blockade. Immune cell infiltration, gene expression changes, and tumor growth kinetics were evaluated. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: THT reduced tumor burden through cell death mechanisms, including upregulated ICD marked by calreticulin exposure within 48 hours. By 48 hours, CD45+ immune cell levels were increased, including increased levels of immunosuppressive M2 macrophages. While THT led to innate immune cell stimulations highlighted by gene expression upregulation in the STING cGAS pathway and enhanced M1 and dendritic cell levels, tumor regrowth was observed within six days post-treatment. To enhance THT&#39;s immunogenic effects, the therapy was combined with intratumoral interleukin-2 (it IL-2) or systemic PD-1 immune checkpoint blockade. Sequential administration of it IL-2 post-THT induced robust CD8+ T-cell infiltration and led to sustained tumor regression in both treated and distant tumors, accompanied by the emergence of memory T cells. However, IL-2-induced immunosuppressive T-reg populations were also sustained to tumor endpoint suggesting that therapy could be further enhanced. Additionally, PD-1 expression, which was upregulated in CD8+ T cells by THT, was targeted with systemic PD-1 inhibition, further augmenting immune engagement within the TME. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> DISCUSSION: These combinatory treatments demonstrated synergistic effects, promoting durable anti-tumor responses and immune memory. Collectively, GNR-mediated THT effectively reduces tumor burden and remodels the TME, potentiating systemic immunity and enhancing the impact of complementary immunotherapies.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39872527/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872527</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769938/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769938</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2024.1512543>10.3389/fimmu.2024.1512543</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39872527</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Barry E Kennedy</dc:creator><dc:creator> Erin B Noftall</dc:creator><dc:creator> Cheryl Dean</dc:creator><dc:creator> Alexander Roth</dc:creator><dc:creator> Kate N Clark</dc:creator><dc:creator> Darren Rowles</dc:creator><dc:creator> Kulbir Singh</dc:creator><dc:creator> Len Pagliaro</dc:creator><dc:creator> Carman A Giacomantonio</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>Targeted intra-tumoral hyperthermia using uniquely biocompatible gold nanorods induces strong immunogenic cell death in two immunogenically &#39;cold&#39; tumor models</dc:title><dc:identifier> pmid:39872527</dc:identifier><dc:identifier> pmc:PMC11769938</dc:identifier><dc:identifier> doi:10.3389/fimmu.2024.1512543</dc:identifier></item><item><title> AIP56, an AB toxin secreted by &lt;em>;Photobacterium damselae&lt;/em>; subsp. &lt;em>;piscicida&lt;/em>;, has tropism for myeloid cells</title><link/> https://pubmed.ncbi.nlm.nih.gov/39872526/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=101560960&amp;fc=None&amp;ff=20250128151106&amp;v=2.18.0.post9+e462414<description> CONCLUSION: AIP56 has tropism for sea bass, mouse and human myeloid cells, with greater affinity for macrophages. This points to an evolutionary conservation of its receptor(s) and mechanism of action across species, raising the possibility that AIP56-like and -related toxins may also play a role in pathogenesis. These findings are relevant for both pathogenicity and biomedical contexts. </description><content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>前免疫</b>。 2025 Jan 13;15:1527088. doi: 10.3389/fimmu.2024.1527088.环保2024。</p><p><b>抽象的</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> INTRODUCTION: The AB-type toxin AIP56 is a key virulence factor of Photobacterium damselae subsp. piscicida (Phdp), inducing apoptosis in fish immune cells. The discovery of AIP56-like and AIP56-related toxins in diverse organisms, including human-associated Vibrio strains, highlights the evolutionary conservation of this toxin family, suggesting that AIP56 and its homologs may share conserved receptors across species. These toxins have potential for biotechnological applications, such as therapeutic protein delivery and immune modulation. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> METHODS: Herein, the cell specificity of AIP56 for immune cells was characterized. The tropism of AIP56 for cells of the sea bass, mouse and human immune system was analyzed by following toxin internalization by flow cytometry and arrival of the toxin in the cytosol by evaluating the cleavage of NF-kB p65 by western blotting. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> RESULTS: Only a small population of sea bass neutrophils internalized AIP56, indicating that most of the neutrophilic destruction during Phdp infection and/or AIP56 intoxication does not result from the direct action of the toxin. Moreover, the cellular tropism of AIP56 for myeloid cells was observed in the three species, including its preference for macrophages. Further, mouse and human M0 and M2-like macrophages internalized more toxin than M1-like macrophages. Despite the limited interaction of lymphoid cells with AIP56, mouse B1-cells were able to internalize the toxin, possibly due to its myeloid features. </p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one"> CONCLUSION: AIP56 has tropism for sea bass, mouse and human myeloid cells, with greater affinity for macrophages. This points to an evolutionary conservation of its receptor(s) and mechanism of action across species, raising the possibility that AIP56-like and -related toxins may also play a role in pathogenesis. These findings are relevant for both pathogenicity and biomedical contexts.</p><p style="color: lightgray"> PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39872526/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">39872526</a> | PMC: <a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11769971/?utm_source=Chrome&utm_medium=rss&utm_campaign=journals&utm_content=101560960&ff=20250128151106&v=2.18.0.post9+e462414">PMC11769971</a> | DOI: <a href=https://doi.org/10.3389/fimmu.2024.1527088>10.3389/fimmu.2024.1527088</a></p></div> ]]>;</content:encoded><guid ispermalink="false"> pubmed:39872526</guid><pubDate> Tue, 28 Jan 2025 06:00:00 -0500</pubDate><dc:creator> Inês Lua Freitas</dc:creator><dc:creator> Maria Fátima Macedo</dc:creator><dc:creator> Liliana Oliveira</dc:creator><dc:creator> Pedro Oliveira</dc:creator><dc:creator> Ana do Vale</dc:creator><dc:creator> Nuno MS Dos Santos</dc:creator><dc:date> 2025-01-28</dc:date><dc:source>免疫学领域</dc:source><dc:title>AIP56, an AB toxin secreted by &lt;em>;Photobacterium damselae&lt;/em>; subsp. &lt;em>;piscicida&lt;/em>;, has tropism for myeloid cells</dc:title><dc:identifier> pmid:39872526</dc:identifier><dc:identifier> pmc:PMC11769971</dc:identifier><dc:identifier> doi:10.3389/fimmu.2024.1527088</dc:identifier></item></channel></rss>